1. Home
  2. HOWL vs LOAN Comparison

HOWL vs LOAN Comparison

Compare HOWL & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$1.07

Market Cap

64.5M

Sector

Health Care

ML Signal

HOLD

Logo Manhattan Bridge Capital Inc

LOAN

Manhattan Bridge Capital Inc

HOLD

Current Price

$4.88

Market Cap

51.9M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOWL
LOAN
Founded
2017
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
64.5M
51.9M
IPO Year
2021
1999

Fundamental Metrics

Financial Performance
Metric
HOWL
LOAN
Price
$1.07
$4.88
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
517.1K
41.1K
Earning Date
11-04-2025
10-24-2025
Dividend Yield
N/A
9.41%
EPS Growth
N/A
N/A
EPS
N/A
0.46
Revenue
N/A
$7,138,128.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.47
P/E Ratio
N/A
$10.56
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$4.29
52 Week High
$2.38
$6.05

Technical Indicators

Market Signals
Indicator
HOWL
LOAN
Relative Strength Index (RSI) 52.22 56.69
Support Level $0.96 $4.64
Resistance Level $1.03 $4.94
Average True Range (ATR) 0.09 0.12
MACD 0.04 0.05
Stochastic Oscillator 96.55 91.20

Price Performance

Historical Comparison
HOWL
LOAN

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

Share on Social Networks: